Before We Start
Not one mechanism, but several checkpoints that can each fail
The immune system has multiple layers designed to prevent it from attacking the body's own tissue. Autoimmunity results when one of those specific layers fails — and different diseases fail at genuinely different layers.
💡 Memory Trick
Autoimmunity = failure of self-tolerance. Central (thymus/bone marrow) or peripheral (Treg failure). Molecular mimicry is a specific triggering mechanism, distinct from either tolerance layer failing outright.
The Key Points
Central tolerance, peripheral tolerance, and specific failure mechanisms
CT
Central tolerance — deleting self-reactive cells before they're ever released
Central tolerance happens during lymphocyte development. In the thymus, T cells that react too strongly to self-antigens are deleted — a process called negative selection, guided by the AIRE gene, which allows the thymus to display a broad sample of the body's own proteins for this screening. Autoreactive B cells undergo a similar deletion process in the bone marrow.
🦠 Mutations in the AIRE gene impair this thymic screening process and cause APECED syndrome, a rare condition marked by multiple autoimmune diseases developing simultaneously, since self-reactive T cells that should have been deleted are instead released into circulation.
PT
Peripheral tolerance — a backup system for cells that slip through
Central tolerance isn't perfect — some self-reactive lymphocytes do slip through regardless. Peripheral tolerance is the backup system: regulatory T cells (Tregs, marked as CD4+CD25+FoxP3+) actively suppress autoreactive cells, and mechanisms like anergy and activation-induced cell death (AICD) provide additional layers of control outside the thymus and bone marrow.
🦠 Tregs actively suppressing a self-reactive T cell that escaped thymic deletion is a direct example of peripheral tolerance catching what central tolerance missed.
Fail
Failure mechanisms — how tolerance actually breaks down
Autoimmunity results when both these tolerance layers fail. Molecular mimicry occurs when a pathogen's proteins closely resemble the body's own proteins, so an immune response against the pathogen accidentally also targets self-tissue. Bystander activation and Treg deficiency are other common routes to the same end outcome — self-reactive cells escaping suppression by a different path.
🦠 Rheumatic fever develops when antibodies produced against Group A Streptococcus cross-react with cardiac tissue, due to molecular mimicry between streptococcal proteins and proteins in heart valve tissue — leading to autoimmune damage to the heart.
🏥 Applied Scenario
A patient develops joint pain and cardiac symptoms several weeks after a streptococcal throat infection.
Step 1
Identify the mechanism: How could an infection cause the body to attack its own heart tissue? Through molecular mimicry — the antibodies generated against streptococcal M protein happen to cross-react with proteins in cardiac tissue, since the two protein structures closely resemble one another.
Step 2
Contrast with a different autoimmune disease: This is different from a scenario like Type 1 diabetes, where autoimmune destruction of pancreatic beta cells isn't necessarily triggered by a specific cross-reactive infection, but more often reflects a broader breakdown in central and peripheral tolerance checkpoints, combined with genetic predisposition via HLA-DR3/4.
Step 3
Recognize the underlying lesson: The molecular mimicry scenario (rheumatic fever) versus a broader tolerance-checkpoint failure (Type 1 diabetes) illustrates that "autoimmunity" isn't one single mechanism — exams expect you to identify which failure pathway fits a given clinical picture, not just recognize that autoimmunity occurred.
Step 4
Conclusion: Two autoimmune diseases can look superficially similar (immune system attacking self-tissue) while arising from genuinely different underlying failures — infection-triggered mimicry versus a broader tolerance breakdown.
📌 Exam Application
Exams test the distinction between central tolerance (thymic/bone marrow deletion, AIRE gene, and what happens when AIRE fails — APECED syndrome) and peripheral tolerance (Tregs, anergy, AICD), plus specific failure mechanisms like molecular mimicry, using classic examples: rheumatic fever, T1DM, SLE, RA, and Graves' disease.
⚠️ The Trap — Treating Autoimmunity as a Single Mechanism
The most common trap is treating "autoimmunity" as a single mechanism rather than recognizing it results from a failure at one of several distinct checkpoints — central tolerance, peripheral tolerance, or a specific triggering event like molecular mimicry. Exam questions often expect you to identify which checkpoint failed in a given scenario, not just recognize that autoimmunity occurred somewhere in the process.
✓ Quick Self-Test
Answer before checking:
1. Where does central tolerance occur, and what gene helps drive it in the thymus?
2. What condition results from a mutation in the AIRE gene?
3. What cells provide peripheral tolerance, and what marker identifies them?
4. What is molecular mimicry, and give a clinical example.
5. Name two other classic examples of autoimmune disease mentioned besides rheumatic fever.
Answers:
1. In the thymus (for T cells) and bone marrow (for B cells); the AIRE gene enables the thymus to display self-antigens for negative selection screening.
2. APECED syndrome, marked by multiple simultaneous autoimmune diseases due to failed thymic deletion of self-reactive T cells.
3. Regulatory T cells (Tregs), marked as CD4+CD25+FoxP3+.
4. When a pathogen's proteins closely resemble the body's own proteins, causing an immune response against the pathogen to also target self-tissue; example: rheumatic fever, where anti-streptococcal antibodies cross-react with cardiac tissue.
5. Type 1 diabetes mellitus (autoimmune destruction of pancreatic beta cells) and Graves' disease (autoimmune stimulation via anti-TSH-receptor antibodies), among others like SLE and RA.
Next Lesson
Immunological Memory
→